Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Smid

Showing results (81-90 of 128) with videos related to

Pageof 13
Sort By:
Molecular Oncology|January 28, 2014
DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivityMarijn T M van Jaarsveld, Maikel D Wouters, Antonius W M Boersma, et al.
Breast Cancer Research : BCR|April 23, 2013
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAsMuhammad Riaz, Marijn T M van Jaarsveld, Antoinette Hollestelle, et al.
Nature Communications|January 26, 2021
Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis featuresPauline A J Mendelaar, Marcel Smid, Job van Riet, et al.
Nature Communications|May 27, 2021
Author Correction: Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis featuresPauline A J Mendelaar, Marcel Smid, Job van Riet, et al.
Plos One|September 18, 2014
Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypesCorine M Beaufort, Jean C A Helmijr, Anna M Piskorz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
A pharmacogenetic predictive model for paclitaxel clearance based on the DMET platformAnne-Joy M de Graan, Laure Elens, Marcel Smid, et al.
International Journal of Cancer|December 31, 2013
MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressorsCaroline M M Gits, Patricia F van Kuijk, Moniek B E Jonkers, et al.
Oncotarget|December 15, 2015
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancerTommaso De Marchi, Anne M Timmermans, Marcel Smid, et al.
Cancers|May 9, 2018
The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to OutcomeIngeborg E de Kruijff, Anna M Timmermans, Michael A den Bakker, et al.
Nature Communications|July 7, 2019
Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genesEsmee Koedoot, Michiel Fokkelman, Vasiliki-Maria Rogkoti, et al.
Pageof 13

Showing results (81-90 of 128) with videos related to

Sort By:
Pageof 13
Molecular Oncology|January 28, 2014
DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivityMarijn T M van Jaarsveld, Maikel D Wouters, Antonius W M Boersma, et al.
Breast Cancer Research : BCR|April 23, 2013
miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAsMuhammad Riaz, Marijn T M van Jaarsveld, Antoinette Hollestelle, et al.
Nature Communications|January 26, 2021
Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis featuresPauline A J Mendelaar, Marcel Smid, Job van Riet, et al.
Nature Communications|May 27, 2021
Author Correction: Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis featuresPauline A J Mendelaar, Marcel Smid, Job van Riet, et al.
Plos One|September 18, 2014
Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypesCorine M Beaufort, Jean C A Helmijr, Anna M Piskorz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2013
A pharmacogenetic predictive model for paclitaxel clearance based on the DMET platformAnne-Joy M de Graan, Laure Elens, Marcel Smid, et al.
International Journal of Cancer|December 31, 2013
MicroRNA expression profiles distinguish liposarcoma subtypes and implicate miR-145 and miR-451 as tumor suppressorsCaroline M M Gits, Patricia F van Kuijk, Moniek B E Jonkers, et al.
Oncotarget|December 15, 2015
Annexin-A1 and caldesmon are associated with resistance to tamoxifen in estrogen receptor positive recurrent breast cancerTommaso De Marchi, Anne M Timmermans, Marcel Smid, et al.
Cancers|May 9, 2018
The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to OutcomeIngeborg E de Kruijff, Anna M Timmermans, Michael A den Bakker, et al.
Nature Communications|July 7, 2019
Uncovering the signaling landscape controlling breast cancer cell migration identifies novel metastasis driver genesEsmee Koedoot, Michiel Fokkelman, Vasiliki-Maria Rogkoti, et al.
Pageof 13